Overview
Dr. Sherronda Henderson is Division Director of Hematology/Oncology at Baylor Scott and White, Central Texas Market. She is a medical oncologist with a specialization in genitourinary oncology - prostate, bladder, kidney, and testicular cancers. She has been the primary investigator of multiple clinical trials in genitourinary oncology and is the oncology lead of the multidisciplinary genitourinary tumor board. Dr. Henderson is Associate Program Director of the Hematology/Oncology Fellowship and an Assistant Professor of Medicine with Baylor College of Medicine, serving as a member of the Admissions Interview Subcommittee. She is passionate about empowering her patients with knowledge about their disease, fostering a collaborative partnership, and working together as a team to deliver the highest standard of cancer care. Dr. Henderson's areas of expertise include prostate cancer, bladder cancer, kidney cancer, and testicular cancer. Connect with Dr. Henderson: Baylor College of Medicine Sherronda Henderson, MD, FACP | LinkedIn Dr. Henderson on Doximity.
Dr. Henderson is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Familial Wilms Tumor 2, Bone Marrow Aspiration, and Endoscopy.
Her clinical research consists of co-authoring 5 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- EPO
- HMO
- PPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- POS
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
2401 S 31st St, Temple, TX 76508
2401 S 31st St, Temple, TX 76508
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Baylor Scott & White Vasicek Cancer Treatment Center - Temple
After completing his residency and fellowship at Scott & White, Dr. Gowan has spent his entire 20-year professional career in Temple, TX. Initially, he was at Scott & White Memorial which became Baylor Scott & White Health. His primary focus is on thoracic cancers and malignancies of the head and neck. Dr. Gowan's areas of expertise include lung cancer and head and neck cancer. Dr. Gowan is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Lung Adenocarcinoma, Bone Marrow Aspiration, and Endoscopy.
Lonestar Oncology
Derrick Nguyen is an Oncologist in Georgetown, Texas. Dr. Nguyen is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. His top areas of expertise are Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), Anemia, and Colorectal Cancer.
Baylor Scott & White Vasicek Cancer Treatment Center - Temple
Dr. Bhat is a board-certified hematologist/ medical oncologist who has formed a niche in breast oncology. She joined BSW at Temple's main campus in 2011 soon after completing her fellowship, and her medical practice mostly consists of breast cancer patients. She also supervises the trainee fellows in their continuity clinic and is one of the core faculty in Baylor Scott & White's 3-year hem-oncology fellowship program. Dr. Bhat has been the site director of NSABP and is currently the chair of the breast tumor board, a weekly interdisciplinary case discussion conference, where NCCN guidelines and optimal treatment options for all their breast cancer patients are discussed. She is passionate about taking care of breast cancer patients and believes in providing them with a comprehensive, yet personalized care plan when it comes to their cancer. Their clinic offers several state-of-the-art treatments like novel chemotherapies, biotherapies, targeted therapies, and immunotherapies. In addition to these standard treatments, she strives to bring on relevant and pertinent clinical trials that would benefit our breast cancer patients. She frequently offers second and third-opinion consults on complicated cases that are referred from our peripheral clinics. Dr. Bhat is rated as a Distinguished provider by MediFind in the treatment of Lung Adenocarcinoma. Her top areas of expertise are Angiosarcoma, Inflammatory Breast Cancer, Breast Cancer, Bone Marrow Aspiration, and Endoscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Chromophobe Renal Cell CarcinomaDr. Henderson isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Familial Wilms Tumor 2Dr. Henderson isDistinguished. Learn about Familial Wilms Tumor 2.
- Lung AdenocarcinomaDr. Henderson isDistinguished. Learn about Lung Adenocarcinoma.
- Paget Disease of the BreastDr. Henderson isDistinguished. Learn about Paget Disease of the Breast.
- Small Cell Lung Cancer (SCLC)Dr. Henderson isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Teratoma of the MediastinumDr. Henderson isDistinguished. Learn about Teratoma of the Mediastinum.
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Henderson isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Henderson isAdvanced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung CancerDr. Henderson isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- Bladder CancerDr. Henderson isAdvanced. Learn about Bladder Cancer.
- Experienced
- Acute Promyelocytic LeukemiaDr. Henderson isExperienced. Learn about Acute Promyelocytic Leukemia.
- Ampullary CancerDr. Henderson isExperienced. Learn about Ampullary Cancer.
- Anaplastic Thyroid CancerDr. Henderson isExperienced. Learn about Anaplastic Thyroid Cancer.
- AngiosarcomaDr. Henderson isExperienced. Learn about Angiosarcoma.
- Bone Marrow AspirationDr. Henderson isExperienced. Learn about Bone Marrow Aspiration.
- Childhood Acute Myeloid LeukemiaDr. Henderson isExperienced. Learn about Childhood Acute Myeloid Leukemia.